口腔外科領域の顎炎・蜂巣炎に対するSulperazon(SBT/CPZ)の臨床使用成績

書誌事項

タイトル別名
  • Clinical evaluation of sulbactam/cefoperazone (SBT/CPZ Sulperazon) in oromaxillofacial infection and phleqmon in the fields of oral surgery.

この論文をさがす

説明

Clincal evaluation of sulbactam/cefoperazone was carried out in 10 cases of osteitis of jaw and in 8cases of cellulitis.<BR>1. The clinical efficacy rate was 77.8 % according to the evaluation score on the 3rd day of treatment, and 72.2 % by the doctor's judgement.<BR>2. Of 14 patients who failed to respond to previous antibiotic treatments, 11 (78.6 %) were effectively treated by SBT/CPZ.<BR>3. MICs of SBT/CPZ against aerobic and anaerobic bacteria were low, and SBT/CPZ resistant strains were not found.<BR>4. As for side effects, they were moderate-some diarrhea appeared in one case. Abnormal findings in the hepatic function test were noted in 3 cases, but the changes were not clinically important.<BR>5. These results indicate the usefulness of sulbactam/cefoperazone in the treatment of odontogenic infections.

収録刊行物

  • 歯科薬物療法

    歯科薬物療法 10 (2), 200-206, 1991

    日本歯科薬物療法学会

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390282679705588608
  • NII論文ID
    130004040337
  • DOI
    10.11263/jsotp1982.10.200
  • ISSN
    18844928
    02881012
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
    • Crossref
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ